New 6-Minute-Walking Test Parameter-Distance/Desaturation Index (DDI) Correctly Diagnoses Short-Term Response to Immunomodulatory Therapy in Hypersensitivity Pneumonitis.

Katarzyna B Lewandowska Malgorzata Sobiecka Piotr Wiktor BorosMałgorzata DybowskaInga BarańskaMałgorzata E JędrychAgata GładzkaWitold Z TomkowskiMonika Szturmowicz

Published in: Diagnostics (Basel, Switzerland) (2023)

6MWT may be used as a tool to assess and monitor the response to immunomodulatory therapy in HP patients, especially if indices incorporating both distance and desaturation are used. Based on the present study results, we recommend 6MWD and DDI use, in addition to FVC and TL,co, to monitor treatment efficacy in patients with interstitial lung diseases.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
peritoneal dialysis
stem cells
patient reported outcomes
rheumatoid arthritis
mesenchymal stem cells